4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:动物毒液多肽毒素
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > acid_base_buffer_solution > Smartox/α7 nAChR selective blocker/08CON011-00500/0.5mg
商品详细Smartox/α7 nAChR selective blocker/08CON011-00500/0.5mg
Smartox/α7 nAChR selective blocker/08CON011-00500/0.5mg
Smartox/α7 nAChR selective blocker/08CON011-00500/0.5mg
商品编号: 08CON011-00500
品牌: smartox-biotech
市场价: ¥2433.60
美元价: 1872.00
产地: 美国(厂家直采)
公司:
产品分类: 酸碱缓冲液
公司分类: acid_base_buffer_solution
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

α-conotoxinIMI (alpha-conotoxinIMI)isaconopeptidethathasbeenisolatedfromthevenomoftheconesnailConusimperialis. α-conotoxinIMI actsonpostsynapticmembranes,andbindsontoandinhibitsnicotinicacetylcholinereceptors(nAChR). α-conotoxinIMI isaselectiveblockerof α7homomericnicotinicacetylcholinereceptors (IC50 ~200nM).IthasnoeffectonnAChRscomposedofα2/ß2,α3/ß2,α4/ß2,α2/ß4,α3/ß4,orα4/ß4subunits. α-conotoxinsIMI actsindependentlyofvoltagevalue.Thistoxinishighlyactiveagainsttheneuromuscularreceptorinfrog.


Description:

Productcode:08CON011.Category:NicotinicAcetylcholineReceptor.Tags:156467-85-5,alpha7,bungarotoxin,nachr,nicotinic.

AAsequence: Gly-Cys2-Cys3-Ser-Asp-Pro-Arg-Cys8-Ala-Trp-Arg-Cys12-NH2
Disulfidebonds: Cys2-Cys8 andCys3-Cys12
Length(aa): 12
Formula: C52H78N20O15S4
MolecularWeight: 1352.92Da
Appearance: Whitelyophilizedsolid
Solubility: waterorsalinebuffer
CASnumber: [156467-85-5]Source: Synthetic
Purityrate: >95%

Reference:

Alpha-conotoxinsImIandImII.Similaralpha7nicotinicreceptorantagoNISTsactatdifferentsites

Anovelconotoxin,alpha-conotoxinImII(alpha-CTxImII),identifiedfromConusimperialisvenomducts,waschemicallysynthesized.ApreviouslycharacterizedC.imperialisconotoxin,alpha-conotoxinImI(alpha-CTxImI),iscloselyrelated;9of12aminoacidsareidentical.Bothalpha-CTxImIIandalpha-CTxImIfunctionallyinhibitheterologouslyexpressedratalpha7nAChRswithsimilarIC(50)values.FurThermore,theBIOLOGicalactivitiesofintracraniallyappliedalpha-CTxImIandalpha-CTxImIIaresimilaroverthesamedosagerange,andareconsistentwithalpha7nAChRinhibition.However,unlikealpha-CTxImI,alpha-CTxImIIwasnotabletoblockthebindingofalpha-bungarotoxintoalpha7nAChRs.alpha-ConotoxinImIandalpha-bungarotoxin-bindingsiteshavebeenwellcharacterizedasoverlappingandlocatedatthecleftbetweenadjacentnAChRsubunits.Becausealpha-CTxImIandalpha-CTxImIIshareextensivesequencehomology,theinABIlityofalpha-CTxImIItocompetewithalpha-BgTxissurprising.Furthermore,functionalstudiesinoocytesindicatethatthereisnooverlapbetweenfunctionalbindingsitesofalpha-CTxImIandalpha-CTxImII.Likealpha-CTxImI,theblockbyalpha-CTxImIIisvoltage-independent.Thus,alpha-CTxImIIrepresentsaprobeforanovelantagonistbindingsite,ormicrosite,onthealpha7nAChR.

Ellison,M., etal. (2003)Alpha-conotoxinsImIandImII.Similaralpha7nicotinicreceptorantagonistsactatdifferentsites, JBiolChem. PMID: 12384509

Structure-activityrelationshipsinapeptidicalpha7nicotinicacetylcholinereceptorantagonist

Alpha-Conotoxinsaresmalldisulfide-constrainedpeptidetoxinswhichactasantagonistsatspecificsubtypesofnicotinicacetylcholinereceptors(nAChreceptors).Inthisstudy,weanalyzedthestructuresandactivitiesofthreemutantsofalpha-conotoxinImI,a12aminoacidpeptideactiveatalpha7nAChreceptors,inordertogaininsightintotheprimaryandtertiarystructuralrequirementsofneuronalalpha-conotoxinspecificity.NMRsolutionstructuresweredeterminedformutantsR11E,R7L,andD5N,resultinginrepresentativeensemblesof20conformerswithaveragepairwiseRMSDvaluesof0.46,0.52,and0.62Afromtheirmeanstructures,respectively,forthebackboneatomsN,C(alpha),andC’ofresidues2-11.TheR11Emutantwasfoundtohaveactivitynearthatofwild-typeImI,whileR7LandD5Ndemonstratedactivitiesreducedbyatleasttwoordersofmagnitude.Comparisonofthestructuresrevealsacommontwo-looparchitecture,withvariationsobservedinbackboneandside-chaindihedralanglesaswellassurfaceelectrostaticpotentialsuponmutation.Correlationofthesestructuresandactivitieswiththosefrompreviouslypublishedstudiesemphasizesthatexistinghypothesesregardingthemoleculardeterminantsofalpha-conotoxinspecificityarenotadequateforexplainingpeptideactivity,andsuggeststhatmoresubtlefeatures,visualizedhereattheatomiclevel,areimportantforreceptorbinding.Thesedata,inconjunctionwithreportedcharacterizationsoftheacetylcholinebindingsite,supportamodeloftoxinactivityinwhichasinglesolvent-accessIBLetoxinside-chainanchorsthecomplex,withsupportingweakinteractionsdeterminingboththeefficacyandthesubtypespecificityoftheinhibitoryactivity.

Rogers,J.P., etal.(2000)Structure-activityrelationshipsinapeptidicalpha7nicotinicacetylcholinereceptorantagonist, JMolBiol. PMID: 11124036

alpha-ConotoxinImIexhibitssubtype-specificnicotinicacetylcholinereceptorblockade:preferentialinhibitionofhomomericalpha7andalpha9receptors

Throughastudyofcloned nicotinic receptorsexpressedinXenopusoocytes,weprovideevidencethat alpha-conotoxin ImI,apeptidemarinesnailtoxinthatinducesseizuresinrodents,selectivelyblockssubtypesof nicotinic acetylcholine receptors. alpha-Conotoxin ImI blocks homomeric alpha 7nicotinic receptorswiththehighestapparentaffinityand homomeric alpha 9receptorswith8-foldloweraffinity.Thistoxinhasnoeffectonreceptorscomposedof alpha 2beta2, alpha 3beta2, alpha 4beta2, alpha 2beta4, alpha 3beta4,or alpha 4beta4subunitcombinations.Incontrasttoalpha-bungarotoxin,whichhashighaffinityfor alpha 7, alpha 9,and alpha 1beta1gammadeltareceptors, alpha-conotoxin ImI haslowaffinityforthemusclenAChR.RelatedConuspeptides, alpha-conotoxinsMIandGI,exhibitadistinctspecificity,strictlytargetingthemusclesubtype receptor butnotalpha 7or alpha 9receptors. alpha-Conotoxinsthusrepresentselectivetoolsforthestudyofneuronal nicotinic acetylcholine receptors.

Johnson,D.S., etal. (1995)Alpha-ConotoxinImIexhibitssubtype-specificnicotinicacetylcholinereceptorblockade:preferentialinhibitionofhomomericalpha7andalpha9receptors, MolPharmacol. PMID: 7651351

Anicotinicacetylcholinereceptorligandofuniquespecificity,alpha-conotoxinImI

Wereporttheisolation,characterization,andtotalsynthesisofasmallpeptideligandfornicotinicacetylcholinereceptors(nAChRs).Itishighlyactiveagainsttheneuromuscularreceptorinfrogbutnotinmice.Incontrast,itinducesseizureswheninjectedcentrallyinmiceandrats,suggestingthatitmaytargetneuronalnAChRsinmammals.Althoughsuchreceptorsmaybeimportantinbothnormalcognitionandthepathophysiologyofseveralneuropsychiatricdisorders,therearefewligandstodiscriminatebetweenthemultiplereceptorsubtypes.Thenewpeptideisahighlydivergentalpha-conotoxinfromthesnailConusimperialis,whichpreysonpolychaeteworms.Inthisarticle,thepurification,structuralanalysis,synthesis,andpreliminaryphysiologicalcharacterizationofalpha-conotoxinImI(alpha-CTx-ImI)arereported.Thesequenceofthepeptideis:Gly-Cys-Cys-Ser-Asp-Pro-Arg-Cys-Ala-Trp-Arg-Cys-NH2.Thepeptideshowsstrikingsequencedifferencesfromallalpha-conotoxinsoffish-huntingConus,butitsdisulfide-bridgingissimilar:[2-8;3-12].WesuggestthatconevenomsmayprovideanarrayofligandswithselectivityforvariousneuronalnAChRsubtypes.

McIntosh,J.M., etal. (1994)Anicotinicacetylcholinereceptorligandofuniquespecificity,alpha-conotoxinImI, J BiolChem. PMID: 8206995

品牌介绍
Smartox Biotechnology 是全球唯一一家专门生产动物毒液多肽毒素,用于细胞离子通道功能研究的生物医药公司。多肽毒素在生物制药领域具有重要的使用价值。Smartox Biotechnology 于 2009 年由来自 Grenoble 神经科学研究所 (Grenoble Institute of Neuroscience) 的 Michel de waard 博士创立, Smartox Biotechnology 专门研究动物毒液,制作合成多种毒液中的多肽成分(常称为毒素)。 De Waard 博士研究离子通道与毒素多肽的关系,尤其是鉴定、开发毒素多肽作为治疗性分子或细胞穿透肽 (cell penetrating peptides, CPP) 。其研究团队在毒液分离,药理性活性肽鉴定、富半胱氨酸肽定性、制作和优化等方面具有独特、丰富的经验。 2010 年, Smartox Biotechnolgy 被法国研究部 (Ministry of Research) 授予“新兴企业 OSEO 奖 (OSEO prize for emerging businesses) ”。